MedPath
HSA Product

REMEDOL 125 SUPPOSITORY 125 mg

Product approved by Health Sciences Authority (SG)

Basic Information

REMEDOL 125 SUPPOSITORY 125 mg

SUPPOSITORY

Regulatory Information

SIN08377P

October 7, 1995

General Sale List

Therapeutic

RECTAL

August 10, 2023

June 3, 2025

XN02BE01

Company Information

REMEDICA LTD

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

PARACETAMOL

Strength: 125 mg

Detailed Information

Contraindications

**Contra-indications** Remedol is contra-indicated in patients with known hypersensitivity to Paracetamol.

Indication Information

**Indications** Remedol tablets are indicated for the treatment of most painful and febrile conditions, for example, headache, toothache, colds, influenza, rheumatic pain and dysmenorrhoea. Remedol suspension is indicated for the treatment of mild to moderate pain (including teething pain), and as antipyretic. Remedol suppositories are indicated for the treatment of conditions associated with fever and pain in children and infants such as tonsillitis, headache, reactions after vaccination, colds, influenza, myalgia and pain following tonsillectomy.

© Copyright 2025. All Rights Reserved by MedPath